Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials
Serena Silvestro, Santa Mammana, Eugenio Cavalli, et al.
Molecules (2019) Vol. 24, Iss. 8, pp. 1459-1459
Open Access | Times Cited: 219

Showing 26-50 of 219 citing articles:

Cannabidiol Acts at 5-HT1A Receptors in the Human Brain: Relevance for Treating Temporal Lobe Epilepsy
Christopher Martínez-Aguirre, Francia Carmona-Cruz, Ana Luisa Velasco, et al.
Frontiers in Behavioral Neuroscience (2020) Vol. 14
Open Access | Times Cited: 49
(‒)-Cannabidiolic Acid, a Still Overlooked Bioactive Compound: An Introductory Review and Preliminary Research
Marialuisa Formato, Giuseppina Crescente, Monica Scognamiglio, et al.
Molecules (2020) Vol. 25, Iss. 11, pp. 2638-2638
Open Access | Times Cited: 48
Pharmacokinetic Drug–Drug Interactions among Antiepileptic Drugs, Including CBD, Drugs Used to Treat COVID-19 and Nutrients
Marta Karaźniewicz−Łada, Anna K. Główka, Aniceta Ada Mikulska, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9582-9582
Open Access | Times Cited: 36
Synergistic Interactions of Cannabidiol with Chemotherapeutic Drugs in MCF7 Cells: Mode of Interaction and Proteomics Analysis of Mechanisms
Muhammad A. Alsherbiny, Deep Jyoti Bhuyan, Mitchell Low, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 10103-10103
Open Access | Times Cited: 36
Phytochemical Constituents and Derivatives of Cannabis sativa; Bridging the Gap in Melanoma Treatment
Ellen Schanknecht, Ava Bachari, Nazim Nassar, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 1, pp. 859-859
Open Access | Times Cited: 14
A phase I trial of the safety, tolerability and pharmacokinetics of cannabidiol administered as single‐dose oil solution and single and multiple doses of a sublingual wafer in healthy volunteers
Adele Hosseini, Andrew J. McLachlan, Jason D. Lickliter
British Journal of Clinical Pharmacology (2020) Vol. 87, Iss. 4, pp. 2070-2077
Open Access | Times Cited: 33
Cannabis sativa subsp. sativa’s pharmacological properties and health effects: A scoping review of current evidence
Xin Yi Lim, Terence Yew Chin Tan, Siti Hajar Muhamad Rosli, et al.
PLoS ONE (2021) Vol. 16, Iss. 1, pp. e0245471-e0245471
Open Access | Times Cited: 30
Glial Cells and Their Contribution to the Mechanisms of Action of Cannabidiol in Neuropsychiatric Disorders
Franciele Franco Scarante, Melissa A. Ribeiro, Ana Flávia Almeida-Santos, et al.
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 30
Virtual screening using docking and molecular dynamics of cannabinoid analogs against CB1 and CB2 receptors
Antistio Aviz-Amador, Neyder Contreras‐Puentes, Jairo Mercado‐Camargo
Computational Biology and Chemistry (2021) Vol. 95, pp. 107590-107590
Closed Access | Times Cited: 29
Therapeutic potential of cannabinoids in combination cancer therapy
Pratibha Malhotra, Ilaria Casari, Marco Falasca
Advances in Biological Regulation (2021) Vol. 79, pp. 100774-100774
Closed Access | Times Cited: 27
Cannabinoids and drug metabolizing enzymes: potential for drug-drug interactions and implications for drug safety and efficacy
Keti Bardhi, Shelby Coates, Christy J. W. Watson, et al.
Expert Review of Clinical Pharmacology (2022) Vol. 15, Iss. 12, pp. 1443-1460
Open Access | Times Cited: 21
<b><i>Cannabis sativa</i></b> and Cannabidiol: A Therapeutic Strategy for the Treatment of Neurodegenerative Diseases?
Milena de Barros Viana, Pedro Everson Alexandre de Aquino, Débora Estadella, et al.
Medical Cannabis and Cannabinoids (2022) Vol. 5, Iss. 1, pp. 207-219
Open Access | Times Cited: 20
Cannabis as a Source of Approved Drugs: A New Look at an Old Problem
Adi Gabarin, Ludmila Yarmolinsky, Arie Budovsky, et al.
Molecules (2023) Vol. 28, Iss. 23, pp. 7686-7686
Open Access | Times Cited: 12
The efficacy and safety of cannabidiol as adjunct treatment for drug‐resistant idiopathic epilepsy in 51 dogs: A double‐blinded crossover study
Aaron J. Rozental, Brooke G. Weisbeck, Isabella Corsato Alvarenga, et al.
Journal of Veterinary Internal Medicine (2023) Vol. 37, Iss. 6, pp. 2291-2300
Open Access | Times Cited: 11
Quantitative analysis of cannabinoids in cannabis sub-species and plant parts using validated HPLC and optimization of decarboxylation for enhanced CBD yield
Mariem Bouali, Ümit Babacan, Mustafa Hamza Mawlood Al Bayatı, et al.
Microchemical Journal (2025), pp. 113454-113454
Closed Access
Utilização de Canabidiol no tratamento de crianças com Transtorno do Espectro Autista
Maria Isabella Papandrea de Carvalho Amaral, Fernanda Ribeiro Marins, Marcelo Limborço Filho
Revista Científica Multidisciplinar Núcleo do Conhecimento (2025), pp. 64-79
Open Access
Optimization of seizure prevention by cannabidiol (CBD)
Bidhan Bhandari, Sahar Emami Naeini, Sholeh Rezaee, et al.
Translational Neuroscience (2025) Vol. 16, Iss. 1
Open Access
BEHAVIORAL AND TRANSCRIPTOMIC EFFECTS OF A NOVEL CANNABINOID ON A RAT VALPROIC ACID MODEL OF AUTISM
Sally Loomis, Dylan E. Da Silva, Ranjev Savopoulos, et al.
Neuropharmacology (2025), pp. 110450-110450
Closed Access
Preliminary Study: Comparison of Antioxidant Activity of Cannabidiol (CBD) and α-Tocopherol Added to Refined Olive and Sunflower Oils
Matilde Tura, Mara Mandrioli, Tullia Gallina Toschi
Molecules (2019) Vol. 24, Iss. 19, pp. 3485-3485
Open Access | Times Cited: 32
The Dichotomous Role of Inflammation in the CNS: A Mitochondrial Point of View
Bianca Vezzani, Marianna Carinci, Simone Patergnani, et al.
Biomolecules (2020) Vol. 10, Iss. 10, pp. 1437-1437
Open Access | Times Cited: 31
Potential Probiotic or Trigger of Gut Inflammation – The Janus-Faced Nature of Cannabidiol-Rich Cannabis Extract
Charles M. Skinner, Intawat Nookaew, Laura Ewing, et al.
Journal of Dietary Supplements (2020) Vol. 17, Iss. 5, pp. 543-560
Open Access | Times Cited: 30
Anticonvulsant Action and Long-Term Effects of Chronic Cannabidiol Treatment in the Rat Pentylenetetrazole-Kindling Model of Epilepsy
Zsolt Gáll, Krisztina Kelemen, Andrea Tolokán, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1811-1811
Open Access | Times Cited: 16
Pharmacokinetics and oral bioavailability of cannabidiol in horses after intravenous and oral administration with oil and micellar formulations
Antonia Sánchez de Medina, Juan Manuel Serrano, E. Díez de Castro, et al.
Equine Veterinary Journal (2023) Vol. 55, Iss. 6, pp. 1094-1103
Closed Access | Times Cited: 10
Archaeosomes facilitate storage and oral delivery of cannabidiol
Viktor Laurin Sedlmayr, Christina Horn, David Johannes Wurm, et al.
International Journal of Pharmaceutics (2023) Vol. 645, pp. 123434-123434
Open Access | Times Cited: 10
Beneficial effects of cannabidiol from Cannabis
Sullim Lee, Yunjeong Lee, Yunseo Kim, et al.
Applied Biological Chemistry (2024) Vol. 67, Iss. 1
Open Access | Times Cited: 3

Scroll to top